N@N

FORT LAUDERDALE, Fla.--([ BUSINESS WIRE ])--Imaging Diagnostic Systems, Inc., (OTCBB:IMDS), a pioneer in laser optical breast imaging announced today that it has sold a CTLM system to a private imaging center near Hangzhou, China. The sale was obtained through its newly assigned exclusive distributor ID-Matrix of China. The system will be shipped during the first week of January 2012.

"Selling a CTLM system in this important emerging market will only further accelerate our goal of it becoming a commonly used method for breast imaging throughout this area. The imaging center will serve as a reference site for future customers in addition to routine patient examinations. We wish our new distributor ID-Matrix continued success as they build the brand CT Laser Mammography," commented Linda Grable/CEO Imaging Diagnostic Systems.

About Imaging Diagnostic Systems, Inc.

Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and shows the process of angiogenesis, which usually accompanies tumor growth. CTLM system has received international certifications and licenses from the European CE mark, CMDCAS Canadian Health screening, China SFDA, India, UL, and ISO 13485. The Company is seeking FDA approval through the Premarket approval process.

For more information, visit our website: [ www.imds.com ]

As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Companyas filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.